Literature DB >> 17903666

Immune response in leukodystrophies.

Florian Eichler1, Keith Van Haren.   

Abstract

Although the genetics and biochemistry of leukodystrophies have been extensively explored, the immune response in these disorders has received relatively little attention. Both the disease course and its response to treatment may be highly dependent on the immune system. In this review, we compare three common leukodystrophies, each with a different immune response: (1) X-linked adrenoleukodystrophy, which demonstrates a severe, lymphocytic inflammatory response; (2) metachromatic leukodystrophy, which yields a histiocytic response; and (3) vanishing white-matter disease, in which no inflammation is typically seen. We highlight the biochemical, pathologic, and clinical differences, while focusing on the immune response in each disease. We also review the response of leukodystrophies to immunomodulatory therapies and interventions such as hematopoietic stem-cell transplantation. Future studies may delineate specific inflammatory markers as possible candidates for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17903666     DOI: 10.1016/j.pediatrneurol.2007.06.011

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

Review 1.  Common and uncommon pathogenic cascades in lysosomal storage diseases.

Authors:  Einat B Vitner; Frances M Platt; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

2.  Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.

Authors:  Sameh K Wasseff; Steven S Scherer
Journal:  Neurobiol Dis       Date:  2015-06-04       Impact factor: 5.996

3.  Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy.

Authors:  Patricia Leonor Musolino; Otto Rapalino; Paul Caruso; Verne Strudwick Caviness; Florian Sebald Eichler
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

Review 4.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

5.  Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Authors:  Charlotte Odendall; Evelyn Dixit; Fabrizia Stavru; Helene Bierne; Kate M Franz; Ann Fiegen Durbin; Steeve Boulant; Lee Gehrke; Pascale Cossart; Jonathan C Kagan
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

Review 6.  Neuroimmunology - the past, present and future.

Authors:  E Nutma; H Willison; G Martino; S Amor
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

7.  Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy.

Authors:  Ashish Gupta; Paul J Orchard; Weston P Miller; Dave R Nascene; Gerald V Raymond; Daniel J Loes; David H McKenna; Troy C Lund
Journal:  Stem Cells Transl Med       Date:  2020-02-05       Impact factor: 6.940

Review 8.  Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases.

Authors:  Marianna Mekhaeil; Kumlesh Kumar Dev; Melissa Jane Conroy
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

9.  Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.

Authors:  Catherine A A Lee; Hannah S Seo; Anibal G Armien; Frank S Bates; Jakub Tolar; Samira M Azarin
Journal:  Fluids Barriers CNS       Date:  2018-04-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.